This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Idogen Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Idogen.
Informations clés
50.6%
Taux de croissance des bénéfices
76.1%
Taux de croissance du BPA
| Biotechs croissance des bénéfices | 46.4% |
| Taux de croissance des recettes | -122.1% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 10 May 2023 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -12 | -12 | -12 | 2 |
| 12/31/2024 | N/A | -12 | -11 | -12 | 2 |
| 12/31/2023 | N/A | -37 | -39 | -38 | 2 |
| 3/31/2023 | 1 | -44 | -42 | -40 | N/A |
| 12/31/2022 | 0 | -48 | -52 | -51 | N/A |
| 9/30/2022 | 3 | -50 | -55 | -53 | N/A |
| 6/30/2022 | 11 | -41 | -54 | -52 | N/A |
| 3/31/2022 | 12 | -39 | -48 | -48 | N/A |
| 12/31/2021 | 14 | -39 | -41 | -40 | N/A |
| 9/30/2021 | 13 | -33 | -36 | -36 | N/A |
| 6/30/2021 | 7 | -33 | -34 | -33 | N/A |
| 3/31/2021 | 8 | -31 | -37 | -36 | N/A |
| 12/31/2020 | 8 | -27 | -28 | -28 | N/A |
| 9/30/2020 | 7 | -27 | -25 | -25 | N/A |
| 6/30/2020 | 6 | -29 | -27 | -27 | N/A |
| 3/31/2020 | 5 | -32 | -25 | -25 | N/A |
| 12/31/2019 | 4 | -33 | -36 | -35 | N/A |
| 9/30/2019 | 7 | -29 | -29 | -28 | N/A |
| 6/30/2019 | 6 | -30 | -28 | -26 | N/A |
| 3/31/2019 | 5 | -27 | -30 | -27 | N/A |
| 12/31/2018 | 4 | -28 | -14 | -10 | N/A |
| 9/30/2018 | N/A | -30 | -24 | -18 | N/A |
| 6/30/2018 | N/A | -29 | -24 | -19 | N/A |
| 3/31/2018 | N/A | -25 | -18 | -12 | N/A |
| 12/31/2017 | N/A | -21 | -24 | -20 | N/A |
| 9/30/2017 | 0 | -18 | -17 | -15 | N/A |
| 6/30/2017 | 0 | -14 | -11 | -9 | N/A |
| 3/31/2017 | 0 | -13 | -12 | -12 | N/A |
| 12/31/2016 | 0 | -13 | N/A | -11 | N/A |
| 9/30/2016 | 0 | -12 | N/A | -12 | N/A |
| 6/30/2016 | 0 | -12 | N/A | -12 | N/A |
| 3/31/2016 | 0 | -10 | N/A | -10 | N/A |
| 12/31/2015 | 0 | -10 | N/A | -9 | N/A |
| 9/30/2015 | 0 | -8 | N/A | -8 | N/A |
| 6/30/2015 | 1 | -6 | N/A | -5 | N/A |
| 3/31/2015 | 0 | -4 | N/A | -3 | N/A |
| 12/31/2014 | 0 | -2 | N/A | -2 | N/A |
| 12/31/2013 | 0 | 0 | N/A | 0 | N/A |
| 12/31/2012 | 0 | 0 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: IDOGEN is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: IDOGEN is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: IDOGEN is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: IDOGEN is forecast to have no revenue next year.
Croissance élevée des revenus: IDOGEN is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if IDOGEN's Return on Equity is forecast to be high in 3 years time